MyMD Pharmaceuticals Inc (NASDAQ: MYMD) open the trading on Thursday, with a bit cautious approach as it glided -0.50% to $1.98, before settling in for the price of $1.99 at the close. Taking a more long-term approach, MYMD posted a 52-week range of $1.90-$65.85.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
In the past 5-years timespan, the Healthcare sector firm’s annual sales growth was -20.00%. Meanwhile, its Annual Earning per share during the time was 67.29%. This publicly-traded company’s shares outstanding now amounts to $2.31 million, simultaneously with a float of $2.12 million. The organization now has a market capitalization sitting at $4.57 million. At the time of writing, stock’s 50-day Moving Average stood at $2.4854, while the 200-day Moving Average is $9.1125.
MyMD Pharmaceuticals Inc (MYMD) Ownership Facts and Figures
Sometimes it helps to make our mind if we keep our tabs on how bigger investors are working with the stock of the Biotechnology industry. MyMD Pharmaceuticals Inc’s current insider ownership accounts for 8.22%, in contrast to 40.09% institutional ownership. According to the most recent insider trade that took place on Aug 24 ’23, this organization’s Chief Legal Officer bought 150,000 shares at the rate of 1.11, making the entire transaction reach 166,500 in total value, affecting insider ownership by 400,000. Preceding that transaction, on Aug 17 ’23, Company’s Chief Legal Officer bought 25,000 for 1.12, making the whole transaction’s value amount to 28,080. This particular insider is now the holder of 250,000 in total.
MyMD Pharmaceuticals Inc (NASDAQ: MYMD) Trading Performance Indicators
Let’s observe the current performance indicators for MyMD Pharmaceuticals Inc (MYMD). It’s Quick Ratio in the last reported quarter now stands at 0.62. The Stock has managed to achieve an average true range (ATR) of 0.18.
In the same vein, MYMD’s Diluted EPS (Earnings per Share) trailing twelve months is recorded -9.52.
Technical Analysis of MyMD Pharmaceuticals Inc (MYMD)
[MyMD Pharmaceuticals Inc, MYMD] recent stats showed that its last 5-days Average volume was superior the volume it posted in the year-ago period. During the previous 9 days, stock’s Stochastic %D was recorded 13.20% While, its Average True Range was 0.1560.
Raw Stochastic average of MyMD Pharmaceuticals Inc (MYMD) in the period of the previous 100 days is set at 1.76%, which indicates a major fall in contrast to 11.43% during the last 2-weeks. If we go through the volatility metrics of the stock, In the past 14-days, Company’s historic volatility was 82.09% that was lower than 99.24% volatility it exhibited in the past 100-days period.
